Advanced search×

NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

Matthew H MH Kulke, Lowell B LB Anthony, David L DL Bushnell, Wouter W WW de Herder, Stanley J SJ Goldsmith, David S DS Klimstra, Stephen J SJ Marx, Janice L JL Pasieka, Rodney F RF Pommier, James C JC Yao, Robert T RT Jensen, and

Pancreas 39(6):735-52 (2010) PMID 20664472

Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies.

DOI: 10.1097/MPA.0b013e3181ebb168
Version: za2963e q8zac q8zb6 q8zce q8zd2 q8ze4 q8zfc q8zgd
View PDF

Similar articles you may find interesting…

  1. In Reply
    M H Kulke and C S Fuchs

    J Clin Oncol 27(2):320-320 (2009)

  2. The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcino...
    Jonathan R Strosberg, Domenico Coppola, ... North American Neuroendocrine Tumor Society (NANETS)

    Pancreas 39(6):799-800 (2010) PMID 20664477

    Extrapulmonary poorly differentiated neuroendocrine carcinomas can originate in the gastrointestinal tract, bladder, cervix, and prostate. These high-grade malignancies are characterized by aggressive histological features (high mitotic rate, extensive necrosis, and nuclear atypia) and a poor clinic...
    View PDF
  3. Accomplishments in 2008 in the management of gastrointestinal neuroendocrine tumors.
    Matthew H Kulke and Hans Scherübl

    Gastrointest Cancer Res 3(5 Supplement 2):S62-6 (2009) PMID 20011568

    View PDF